DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Caplin Point Laboratories Limited — Investor Presentation

NSE 57 min ago·12 Aug 2026, 9:36 am

Company NSE

Caplin Point Laboratories Limited has released its latest investor presentation to the stock exchanges. This document typically outlines the company's strategic plans, financial performance, and future outlook for the upcoming quarters.

For investors, this update is a key opportunity to understand management's vision. It provides clarity on how the company plans to navigate the current market environment and achieve its growth targets.

Investors should pay close attention to the guidance provided regarding revenue growth, margin expansion, and operational efficiency. These details are crucial for assessing the company's long-term potential.